Novo Holdings A/S 13D and 13G filings for Milestone Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-10-24 12:46 pm Sale | 2022-10-20 | 13D | Milestone Pharmaceuticals Inc. MIST | Novo Holdings A/S | 1,378,538 4.600% | -719,175 (-34.28%) | Filing |
| 2022-09-26 4:04 pm Purchase | 2022-09-20 | 13D | Milestone Pharmaceuticals Inc. MIST | Novo Holdings A/S | 2,097,713 7.000% | 16,828 (+0.81%) | Filing |